Fan Shengxian, Ni Xiaodong, Wang Jian, Zhang Yongliang, Tao Shen, Chen Mimi, Li Yousheng, Li Jieshou
From the Department of Surgery, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China.
Medicine (Baltimore). 2016 Feb;95(6):e2640. doi: 10.1097/MD.0000000000002640.
The implications of low triiodothyronine syndrome (LT3S) in patients with radiation enteritis (RE) have not been properly investigated. As such, we conducted this cohort study to investigate the association between LT3S and RE, to explore the etiology of LT3S in RE, to evaluate the clinical features and clinical outcomes of LT3S patients, and to inspect the correlation of clinical variables and LT3S in RE.This prospective study included 39 RE patients. Medical records and various laboratory parameters (including thyroidal, tumorous, nutritional, and radiotherapy variables) were collected in all participants.Our results showed that the incidence of LT3S was 84.6% in patients with RE. Total protein (71.7 ± 5.7 vs 63.2 ± 9.6 g/L, P = 0.04) and albumin (ALB, 46.0 ± 4.6 vs 38.7 ± 5.3 g/L, P = 0.01) were significantly lower in LT3S group compared with those in euthyroid group. Standard thyroid-stimulating hormone index (-0.89 ± 2.11 vs -2.39 ± 1.33, P = 0.03) and sum activity of deiodinases (19.74 ± 4.19 vs 12.55 ± 4.32 nmol/L, P = 0.01) were significantly lower in LT3S group. Patients with LT3S suffered longer duration of hospitalization (48.25 ± 23.29 days in LT3S vs 26.75 ± 10.56 days in euthyroid, P = 0.036). Low serum ALB (β = 0.694, 95% CI = 0.007-0.190, P = 0.037) was the only significant predictor of LT3S.LT3S was common in RE patients. A hypodeiodination condition and a potential pituitary-thyrotroph dysfunction might play a role in the pathophysiology of LT3S in RE. Worse nutritional status and clinical outcomes were confirmed in RE patients with LT3S. Furthermore, total protein and ALB were observed as protective and differentiating parameters of LT3S in RE. In summary, this was the 1st investigation to evaluate the clinical correlation between RE and LT3S, investigate the prevalence of LT3S in RE, and explore the pathogenesis of LT3S, despite the limitation of a relatively small sample size. These results will hopefully encourage future research to place greater emphasis on early identification of LT3S in RE patients.
低三碘甲状腺原氨酸综合征(LT3S)在放射性肠炎(RE)患者中的影响尚未得到充分研究。因此,我们进行了这项队列研究,以调查LT3S与RE之间的关联,探讨RE中LT3S的病因,评估LT3S患者的临床特征和临床结局,并检查RE中临床变量与LT3S的相关性。这项前瞻性研究纳入了39例RE患者。收集了所有参与者的病历和各种实验室参数(包括甲状腺、肿瘤、营养和放疗变量)。我们的结果显示,RE患者中LT3S的发生率为84.6%。LT3S组的总蛋白(71.7±5.7 vs 63.2±9.6 g/L,P = 0.04)和白蛋白(ALB,46.0±4.6 vs 38.7±5.3 g/L,P = 0.01)明显低于甲状腺功能正常组。LT3S组的标准促甲状腺激素指数(-0.89±2.11 vs -2.39±1.33,P = 0.03)和脱碘酶总活性(19.74±4.19 vs 12.55±4.32 nmol/L,P = 0.01)明显较低。LT3S患者的住院时间更长(LT3S组为48.25±23.29天,甲状腺功能正常组为26.75±10.56天,P = 0.036)。低血清ALB(β = 0.694,95%CI = 0.007 - 0.190,P = 0.037)是LT3S的唯一显著预测因素。LT3S在RE患者中很常见。脱碘功能减退状态和潜在的垂体 - 促甲状腺激素功能障碍可能在RE中LT3S的病理生理过程中起作用。LT3S的RE患者营养状况和临床结局更差得到证实。此外,总蛋白和ALB被观察为RE中LT3S的保护和鉴别参数。总之,这是首次评估RE与LT3S之间临床相关性、调查RE中LT3S患病率并探索LT3S发病机制的研究,尽管样本量相对较小存在局限性。这些结果有望鼓励未来的研究更加重视RE患者中LT3S的早期识别。